AstraZeneca has sold its stake in Moderna for more than $1 billion - The Times


  • World
  • Monday, 01 Mar 2021

FILE PHOTO: The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron

(Reuters) - AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.

The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.

AstraZeneca and Moderna did not immediately respond to requests for comment.

AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added.

Moderna, whose vaccine is cleared for emergency use against COVID-19 in the United States, said last week it was expecting sales of $18.4 billion from its coronavirus vaccine this year.

(Reporting by Maria Ponnezhath in Bengaluru; Editing by Jonathan Oatis and Peter Cooney)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In World

In El Salvador, rising inmate numbers threaten humanitarian crisis: NGO
Canada sets up recovery fund for Hurricane Fiona
41st ICAO elects 36 members to new council
S.Korea, U.S. military launch 4 surface-to-surface missiles in response to N.Korea missile test -Yonhap
Jordan signs 100-mln-USD loan with OPEC Fund to enhance food security
U.S. crude oil inventories down: API
North Korean missile launch 'deliberately provocative,' EU says
U.S. agricultural futures close mixed
U.S.-listed Chinese firms trade higher
Oil prices rally ahead of OPEC+ meeting

Others Also Read